Clinical Trial

U87 CAR-T in Patients With Advanced Head and Neck Tumors

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-arm, open-label clinical study to evaluate the safety, tolerability, and efficacy of U87 injection solution in patients with advanced malignant head and neck tumors.
Trial Details
NCT Number NCT06614686
Lead Sponsor Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Conditions Nasopharynx Cancer, Head and Neck Cancer
Enrollment 20 participants
Start Date 2024-09-20
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-26